Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional) | PAR 21 207

Frequently Asked Questions (FAQs)

What is the NIH funding opportunity PAR-21-207 about?

PAR-21-207 is an NIH funding opportunity that supports R01 grant applications for ancillary studies focused on adherence to health-related behavior changes that may help protect brain health and reduce risk for cognitive decline, Mild Cognitive Impairment (MCI), and Alzheimer's disease and related dementias (AD/ADRD). The core focus is on understanding why people do or do not stick with these behavior changes over time.

What is the main scientific emphasis of this opportunity?

The central emphasis is on psychological and interpersonal mechanisms that drive adherence. Instead of primarily asking whether a lifestyle intervention works, the FOA prioritizes identifying modifiable, mechanistic targets that influence whether someone initiates behavior change, maintains it, or re-engages after lapses.

Does this FOA fund broad lifestyle interventions?

No. The FOA is not framed around funding broad lifestyle interventions in general. It is framed around adherence-centered mechanistic questions, meaning the proposal should focus on the underlying factors that explain adherence success or failure rather than only evaluating overall intervention outcomes.

What does NIH mean here by "adherence"?

In this context, adherence refers to whether people start a health-related behavior change, maintain it over time, and restart it after interruptions or lapses. The FOA also emphasizes understanding how adherence mechanisms work and how changing those mechanisms could improve long-term behavior maintenance.

What kinds of mechanistic targets are considered strong fits for applications?

Examples of malleable mechanistic targets highlighted in the opportunity include motivational processes, self-regulation skills, habit formation, planning and goal-setting, self-efficacy, stress and coping, emotion regulation, perceived benefits and barriers, social support dynamics, relationship and caregiver influences, communication patterns, and other interpersonal factors that shape ongoing participation in healthy behaviors.

What populations or health outcomes is the research meant to address?

The research is meant to address behavior-change adherence in ways that could support cognitive health and lower risk for cognitive decline, MCI, and AD/ADRD. The opportunity description centers on cognitive aging and dementia-related outcomes.

What behavior domains are considered relevant to this FOA?

Studies generally align with lifestyle or behavioral domains commonly linked to dementia risk reduction, such as physical activity, diet quality, sleep, cognitive and social engagement, management of cardiometabolic risk factors, or multi-domain behavior change. The distinguishing feature should be a mechanistic, adherence-centered research question.

What grant mechanism is used for PAR-21-207?

This opportunity uses the NIH R01 grant mechanism.

Are clinical trials required under this FOA?

No. Clinical trials are optional. Applicants may propose observational, experimental, or intervention-based studies, as long as the work is structured to test or illuminate mechanisms tied to adherence.

What is an "ancillary study" in the context of this opportunity?

An ancillary study typically adds mechanistic questions, measures, or experimental components onto an existing parent study, cohort, trial, or established research platform. The intent is often to leverage existing recruitment pipelines, participant populations, data collection schedules, or intervention infrastructure while adding elements that clarify why adherence succeeds or fails.

Do applications need to be tied to an existing parent study or platform?

Yes, the FOA specifically calls for ancillary studies, which are generally designed to attach to or leverage an existing study, cohort, trial, or research platform. The provided information indicates the proposed work typically builds on existing infrastructure rather than starting entirely from scratch.

What is NIH hoping applicants will produce beyond showing an intervention works?

NIH is signaling interest in identifying the key changeable targets that reliably strengthen adherence. The goal is to move beyond outcome-only evaluations and instead clarify mechanisms that can be intentionally improved to make behavior change more durable and easier to sustain or restart.

What types of organizations are eligible to apply?

Eligibility is broad and includes many types of U.S. organizations and some non-U.S. entities. Eligible applicants listed include state, county, city, township, and special district governments; independent school districts; public and state-controlled and private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (including small businesses and other for-profits that are not small businesses); and other applicant types.

Are minority-serving institutions and community-based organizations explicitly included?

Yes. The announcement explicitly highlights additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, Historically Black Colleges and Universities, and Tribally Controlled Colleges and Universities. It also lists faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.

Are non-U.S. (foreign) organizations eligible?

Yes. The eligibility description explicitly includes non-domestic (foreign) organizations.

Is this opportunity connected to a specific CFDA number?

Yes. The opportunity is associated with CFDA 93.866, based on the provided source details.

What is the funding activity category for this opportunity?

Based on the provided details, the opportunity falls under the NIH health funding activity category.

When was PAR-21-207 posted and what closing date is shown?

The posting/creation date shown is April 6, 2021, and the original closing date shown is January 26, 2022.

Is the award ceiling or number of expected awards provided?

No. The award ceiling and expected number of awards are not specified in the provided text. The provided summary notes that applicants would typically need to consult the full FOA for budget expectations, institute participation, and any limits or guidance on scope, duration, and allowable costs.

What practical payoff is NIH emphasizing for this research area?

The practical payoff highlighted is better-designed interventions and implementation approaches built around tested mechanisms of adherence, with the aim of making behavior-change support more durable and effective in real-world settings over the long timelines relevant to cognitive aging and AD/ADRD risk.